Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort

BACKGROUND: The standard of care for newly diagnosed glioblastoma is maximal safe surgical resection, followed by chemoradiation therapy. We assessed carmustine wafer implantation efficacy and safety when used in combination with standard care. METHODS: Included were adult patients with (n = 354, im...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Pallud, Johan, Audureau, Etienne, Noel, Georges, Corns, Robert, Lechapt-Zalcman, Emmanuèle, Duntze, Julien, Pavlov, Vladislav, Guyotat, Jacques, Hieu, Phong Dam, Le Reste, Pierre-Jean, Faillot, Thierry, Litre, Claude-Fabien, Desse, Nicolas, Petit, Antoine, Emery, Evelyne, Voirin, Jimmy, Peltier, Johann, Caire, François, Vignes, Jean-Rodolphe, Barat, Jean-Luc, Langlois, Olivier, Dezamis, Edouard, Parraga, Eduardo, Zanello, Marc, Nader, Edmond, Lefranc, Michel, Bauchet, Luc, Devaux, Bertrand, Menei, Philippe, Metellus, Philippe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Clinical Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633930/
https://ncbi.nlm.nih.gov/pubmed/26185110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov126
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak